查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2035481

實驗室自動化市場預測至2034年—按組件、自動化類型、工作流程階段、應用、最終用戶和地區分類的全球分析

Lab Automation Market Forecasts to 2034 - Global Analysis By Component (Equipment, Software & Informatics, and Services), Automation Type, Workflow Stage, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球實驗室自動化市場規模將達到 75 億美元，並在預測期內以 7.8% 的複合年成長率成長，到 2034 年將達到 137 億美元。

實驗室自動化是指利用技術手段實現實驗室環境中諸如檢體處理、分析和數據管理等人工流程的自動化。這些系統包括機器人工作站、自動化液體處理工作站和整合軟體平台，能夠簡化臨床診斷、藥物研發和生物技術領域的工作流程。實驗室自動化的應用正在透過提高處理能力、減少人為錯誤和確保結果可重複性來變革科學研究工作流程。面對日益成長的檢體量和有限的熟練人員，自動化解決方案正成為全球現代科學研究和診斷機構不可或缺的基礎設施。

藥物研發中對高通量篩檢的需求日益成長。

製藥和生技公司正迅速採用實驗室自動化技術，以加速藥物研發流程，縮短新治療方法的上市時間。高通量篩檢需要每天處理數千個樣本，這在保持可接受的準確性和一致性的前提下，人工操作幾乎無法實現。自動化系統使研究人員能夠針對生物標靶測試龐大的化合物庫，從而快速識別有前景的候選藥物，同時消除手動移液帶來的重複性壓力。慢性病盛行率的上升以及由此導致的新療法需求的增加，進一步加劇了這一需求，使得實驗室自動化成為研究機構縮短研發週期、減少救命藥物上市延誤成本的關鍵競爭優勢。

初始投資高且整合複雜

自動化系統高昂的初始成本仍然是其廣泛應用的主要障礙，尤其對於小規模的研究實驗室和學術機構而言更是如此。要實現完全整合的自動化實驗室，需要在機器人平台、專用設備、軟體授權和基礎設施維修投入大量資金。除了硬體成本外，機構還面臨系統整合、工作流程重新設計和員工培訓的巨額支出。將來自不同製造商的各種設備整合到無縫的自動化工作流程中，通常需要機構內部不具備的專業技術知識。這些財務和技術障礙造成了市場分層，只有資金雄厚的機構才能充分受益於全面的自動化解決方案。

將人工智慧 (AI) 整合到智慧自動化中

先進的人工智慧演算法正在革新實驗室自動化，使系統能夠從實驗數據中學習並自主最佳化實驗方案。機器學習模型可以預測最佳檢測條件，即時識別異常結果，並在無需人工干預的情況下提出後續實驗提案。這種智慧自動化不僅限於執行任務，還能進行實驗設計和決策，進而顯著加快科學研究發現的速度。採用人工智慧驅動的自動化技術的實驗室報告稱，方法開發時間顯著縮短，實驗結果也得到改善。隨著人工智慧工具變得更加普及和方便用戶使用，小規模實驗室也能使用這些功能，從而使以往僅限於資金雄厚的工業研究機構的先進自動化技術惠及更多實驗室。

對勞動力更替和技能缺口的擔憂

自動化技術的廣泛應用為實驗室工作人員帶來了營運效率與工作保障之間的矛盾。工程師和科學家擔心自動化會取代他們的日常工作，這種抵觸情緒可能導致實施進度延誤和投資報酬率降低。同時，經驗豐富的實驗室工作人員缺乏機器人技術、軟體整合和數據分析方面的培訓，造成了嚴重的技能缺口。各機構必須投入大量資金用於再培訓項目，同時也要解決過渡期內的士氣問題。人們普遍認為自動化是對就業的威脅，而不是提高生產力的工具，這種觀念造成了文化上的障礙，其難度不亞於技術難題，可能會限制傳統保守的實驗室環境中自動化技術的普及率。

新型冠狀病毒（COVID-19）的影響：

新冠疫情大大加速了檢查室自動化的普及，迫使診斷檢查室處理前所未有的檢測量並快速出具結果。自動化檢體處理系統成為滿足全球檢測需求的關鍵基礎設施，許多機構也因應疫情首次採用自動化技術。疫情也凸顯了人工檢測流程的脆弱性，促使臨床和研究機構進行永久性的操作改革。人工耗材供應鏈的中斷進一步推動了更高效利用試劑的自動化解決方案的轉變。疫苗研發的迫切性展現了自動化在加速臨床試驗的價值，並鞏固了人們對自動化檢查室作為公共衛生關鍵基礎設施的認知。

在預測期內，「全實驗室自動化（TLA）」細分市場預計將佔據最大的市場佔有率。

在預測期內，全實驗室自動化 (TLA) 領域預計將佔據最大的市場佔有率。這指的是完全整合的系統，能夠自動完成從檢體接收到結果報告的整個工作流程，無需人工干預。這些綜合解決方案透過輸送機系統、機械臂和集中式軟體控制，將分析前、分析中和分析後階段連接起來，從而最大限度地提高處理能力並最大限度地減少人工操作時間。大規模臨床診斷檢查室和高通量製藥實驗室更傾向於採用全自動化系統，因為它能夠幫助他們每天處理數千個檢體，並保持品質穩定。檢查室整合和向集中式檢測設施的轉變趨勢，進一步推動了對能夠實現最高營運效率和最快投資回報的全自動化解決方案的需求。

在預測期內，預分析自動化領域預計將呈現最高的複合年成長率。

在預測期內，樣品製備自動化領域預計將呈現最高的成長率，這主要源自於人們認知到樣品製備是實驗室工作流程中最耗費人力且最容易出錯的環節。用於檢體分類、離心、封蓋、檢體裝和追蹤的自動化系統解決了分析開始前的關鍵瓶頸。由於該階段的錯誤無法在後期糾正，因此從品質改進的角度來看，對自動化的投資尤其重要。臨床診斷和生物銀行應用中日益成長的檢體量，使得高效的分析前解決方案需求迫切。技術進步使這些系統更加緊湊、經濟實惠，不僅大規模中心檢查室能夠使用，小規模醫院和研究機構也能從中受益，從而改善工作流程。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其龐大的醫療費用支出、前沿的藥物研發活動以及對先進檢測技術的早期應用。該地區擁有眾多領先的自動化設備製造商，以及大規模需要高效檢體處理解決方案的大型臨床實驗室。來自美國國立衛生研究院 (NIH) 等政府機構的大力研究經費支持持續創新。有利的診斷測試報銷政策和熟練技術人員的存在進一步加速了自動化技術的普及。美國和加拿大檢查室整合和集中化的持續趨勢確保了北美在整個預測期內保持其市場領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療基礎設施的不斷完善、藥物研發投入的增加以及大規模人口對診斷檢測需求的持續成長。中國、印度、日本和韓國等國家正快速推動檢查室網路現代化，以提升其整體醫療體系。該地區的受託研究機構（CRO）正日益走向全球，而具備競爭力的自動化能力對於贏得國際業務至關重要。政府支持生物技術發展和檢查室品質標準的舉措正在加速自動化技術的應用。隨著亞洲主要經濟體人事費用的上升和檢體量的持續成長，檢查室自動化的經濟效益日益顯著，使亞太地區成為成長最快的區域市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球實驗室自動化市場：依組件分類

  • 裝置
    • 自動化工作站
    • 液體處理系統
    • 機器人系統
    • 微孔盤讀數儀
    • 儲存和檢索系統
    • 樣品製備系統
    • 其他設備
  • 軟體和資訊技術
    • 實驗室資訊管理系統（LIMS）
    • 電子實驗室筆記本（ELN）
    • 科學資料管理系統（SDMS）
    • 工作流程自動化軟體
  • 服務
    • 安裝與整合
    • 維護和支援
    • 諮詢服務

第6章 全球實驗室自動化市場：依自動化類型分類

  • 全面實驗室自動化
  • 模組化自動化
  • 任務導向的自動化

第7章 全球實驗室自動化市場：依工作流程階段分類

  • 預分析階段的自動化
  • 分析自動化
  • 分析後自動化

第8章 全球實驗室自動化市場：依應用分類

  • 藥物發現與開發
  • 臨床診斷
  • 基因組學和蛋白​​質組學
  • 微生物學
  • 生物銀行
  • 高通量篩檢
  • 其他用途

第9章 全球實驗室自動化市場：依最終用戶分類

  • 製藥和生物技術公司
  • 臨床和診斷檢查室
  • 學術研究機構
  • 受託研究機構
  • 醫院

第10章 全球實驗室自動化市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Tecan Group Ltd.
  • Hamilton Company
  • Eppendorf SE
  • Qiagen NV
  • Beckman Coulter Inc.
  • Roche Diagnostics International Ltd.
  • Siemens Healthineers AG
  • Hudson Robotics Inc.
  • Aurora Biomed Inc.
  • Becton Dickinson and Company
Product Code: SMRC35694

According to Stratistics MRC, the Global Lab Automation Market is accounted for $7.5 billion in 2026 and is expected to reach $13.7 billion by 2034 growing at a CAGR of 7.8% during the forecast period. Lab automation refers to the use of technology to automate manual processes in laboratory settings, including sample handling, analysis, and data management. These systems encompass robotic workstations, automated liquid handlers, and integrated software platforms that streamline workflows across clinical diagnostics, pharmaceutical research, and biotechnology applications. The adoption of lab automation is transforming scientific workflows by increasing throughput, reducing human error, and enabling reproducibility. As laboratories face mounting pressure to process growing sample volumes with limited skilled personnel, automated solutions are becoming essential infrastructure for modern research and diagnostic facilities worldwide.

Market Dynamics:

Driver:

Increasing demand for high-throughput screening in drug discovery

Pharmaceutical and biotechnology companies are rapidly adopting lab automation to accelerate the drug development pipeline and reduce time-to-market for new therapies. High-throughput screening requires processing thousands of samples daily, a task impossible to achieve manually with acceptable accuracy and consistency. Automated systems enable researchers to test vast compound libraries against biological targets, quickly identifying promising drug candidates while eliminating repetitive strain injuries associated with manual pipetting. The rising prevalence of chronic diseases and the corresponding need for novel therapeutics further intensify this demand, making lab automation a critical competitive advantage for research organizations seeking to shorten development cycles and reduce costly delays in bringing life-saving medications to patients.

Restraint:

High initial capital investment and integration complexity

Significant upfront costs for automated systems continue to challenge widespread adoption, particularly among smaller laboratories and academic research institutions. A fully integrated automated laboratory requires substantial expenditure on robotic platforms, specialized equipment, software licenses, and infrastructure modifications. Beyond hardware costs, organizations face considerable expenses related to system integration, workflow redesign, and staff training. The complexity of connecting disparate instruments from different manufacturers into a seamless automated workflow often demands specialized technical expertise that may not be available internally. These financial and technical barriers create a tiered market where only well-funded facilities can fully benefit from comprehensive automation solutions.

Opportunity:

Artificial intelligence integration for intelligent automation

Advanced AI algorithms are revolutionizing lab automation by enabling systems that learn from experimental data and optimize protocols autonomously. Machine learning models can predict optimal assay conditions, identify anomalous results in real-time, and suggest follow-up experiments without human intervention. This intelligent automation extends beyond simple task execution to experimental design and decision-making, dramatically accelerating the pace of discovery. Laboratories implementing AI-driven automation report significant reductions in method development time and improved experimental outcomes. As AI tools become more accessible and user-friendly, even smaller laboratories can leverage these capabilities, democratizing access to sophisticated automation previously reserved for well-funded industrial research facilities.

Threat:

Workforce displacement concerns and skill gaps

Widespread automation adoption is creating tensions between operational efficiency and employment security among laboratory personnel. Technicians and scientists fear that automation will replace routine jobs, leading to resistance that can slow implementation timelines and undermine return on investment. Simultaneously, a significant skills gap exists as experienced laboratory staff lack training in robotics, software integration, and data analytics. Organizations must invest heavily in retraining programs while managing morale concerns during transitions. The perception of automation as a job threat rather than a productivity tool can create cultural barriers that are as challenging to overcome as technical hurdles, potentially limiting adoption rates in traditionally conservative laboratory environments.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated lab automation adoption as diagnostic laboratories faced unprecedented testing volumes requiring rapid turnaround times. Automated sample processing systems became essential infrastructure for meeting global testing demands, with many facilities implementing automation for the first time in response to crisis conditions. The pandemic also highlighted vulnerabilities in manual laboratory workflows, prompting permanent operational changes across clinical and research settings. Supply chain disruptions for manual consumables further incentivized automated solutions that use reagents more efficiently. The urgent need for vaccine development demonstrated automation's value in accelerating clinical trials, establishing lasting recognition of automated laboratories as critical public health infrastructure.

The Total Laboratory Automation segment is expected to be the largest during the forecast period

The Total Laboratory Automation segment is expected to account for the largest market share during the forecast period, representing fully integrated systems that automate workflows from sample entry through result reporting without manual intervention. These comprehensive solutions connect pre-analytical, analytical, and post-analytical stages through conveyor systems, robotic arms, and centralized software control, maximizing throughput and minimizing hands-on time. Large clinical diagnostic laboratories and high-volume pharmaceutical research facilities prefer total automation for its ability to process thousands of samples daily with consistent quality. The growing trend toward laboratory consolidation and centralized testing facilities further drives demand for complete automation solutions that deliver maximum operational efficiency and fastest return on investment.

The Pre-Analytical Automation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Pre-Analytical Automation segment is predicted to witness the highest growth rate, driven by recognition that sample preparation remains the most labor-intensive and error-prone phase of laboratory workflows. Automated systems for specimen sorting, centrifugation, decapping, aliquot preparation, and sample tracking address critical bottlenecks occurring before analysis begins. Errors in this stage cannot be corrected later, making automation investments particularly valuable for quality improvement. Growing sample volumes across clinical diagnostics and biobanking applications create urgent need for efficient pre-analytical solutions. Technological advances have made these systems more compact and affordable, enabling adoption beyond large central laboratories to smaller hospital and research facilities seeking workflow improvements.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by substantial healthcare spending, leading pharmaceutical research activity, and early adoption of advanced laboratory technologies. The region hosts numerous major automation manufacturers and a dense concentration of high-volume clinical reference laboratories requiring efficient sample processing solutions. Strong research funding from government agencies like the National Institutes of Health supports continuous technology innovation. Favorable reimbursement policies for diagnostic testing and the presence of skilled technical personnel further enable automation deployment. The ongoing trend toward laboratory consolidation and centralized testing facilities across the United States and Canada ensures North America maintains its market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by expanding healthcare infrastructure, rising pharmaceutical research investment, and growing demand for diagnostic testing across large populations. Countries including China, India, Japan, and South Korea are rapidly modernizing laboratory networks as part of broader healthcare system improvements. The region's contract research organizations are gaining global prominence, requiring competitive automation capabilities to win international business. Government initiatives supporting biotechnology development and laboratory quality standards accelerate adoption. As labor costs rise in major Asian economies and sample volumes continue increasing, the economic case for laboratory automation becomes increasingly compelling, positioning Asia Pacific as the fastest-growing regional market.

Key players in the market

Some of the key players in Lab Automation Market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., Hamilton Company, Eppendorf SE, Qiagen N.V., Beckman Coulter Inc., Roche Diagnostics International Ltd., Siemens Healthineers AG, Hudson Robotics Inc., Aurora Biomed Inc. and Becton Dickinson and Company.

Key Developments:

In March 2026, Hamilton announced a partnership with Takara Bio USA to automate NGS library preparation, following a similar co-marketing agreement with Aplex Bio for hyperplex PCR assay kits to enhance molecular diagnostic throughput.

In February 2026, At SLAS2026, Agilent debuted new AI-driven lab optimization tools integrated into its CrossLab Connect platform, utilizing Sigsense technology to provide real-time asset analytics and predictive alerts to reduce instrument downtime.

In January 2026, BD released BD Research Cloud 7.0, featuring the BD Horizon Panel Maker, an AI-powered tool that automates the design of complex flow cytometry panels, reducing the risk of unusable data in immunology and cancer research.

Components Covered:

  • Equipment
  • Software & Informatics
  • Services

Automation Types Covered:

  • Total Laboratory Automation
  • Modular Automation
  • Task-Targeted Automation

Workflow Stages Covered:

  • Pre-Analytical Automation
  • Analytical Automation
  • Post-Analytical Automation

Applications Covered:

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Genomics & Proteomics
  • Microbiology
  • Biobanking
  • High-Throughput Screening
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Clinical & Diagnostic Laboratories
  • Academic & Research Institutes
  • Contract Research Organizations
  • Hospitals

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Lab Automation Market, By Component

  • 5.1 Equipment
    • 5.1.1 Automated Workstations
    • 5.1.2 Liquid Handling Systems
    • 5.1.3 Robotic Systems
    • 5.1.4 Microplate Readers
    • 5.1.5 Storage & Retrieval Systems
    • 5.1.6 Sample Preparation Systems
    • 5.1.7 Other Equipment
  • 5.2 Software & Informatics
    • 5.2.1 Laboratory Information Management Systems (LIMS)
    • 5.2.2 Electronic Lab Notebooks (ELN)
    • 5.2.3 Scientific Data Management Systems (SDMS)
    • 5.2.4 Workflow Automation Software
  • 5.3 Services
    • 5.3.1 Installation & Integration
    • 5.3.2 Maintenance & Support
    • 5.3.3 Consulting Services

6 Global Lab Automation Market, By Automation Type

  • 6.1 Total Laboratory Automation
  • 6.2 Modular Automation
  • 6.3 Task-Targeted Automation

7 Global Lab Automation Market, By Workflow Stage

  • 7.1 Pre-Analytical Automation
  • 7.2 Analytical Automation
  • 7.3 Post-Analytical Automation

8 Global Lab Automation Market, By Application

  • 8.1 Drug Discovery & Development
  • 8.2 Clinical Diagnostics
  • 8.3 Genomics & Proteomics
  • 8.4 Microbiology
  • 8.5 Biobanking
  • 8.6 High-Throughput Screening
  • 8.7 Other Applications

9 Global Lab Automation Market, By End User

  • 9.1 Pharmaceutical & Biotechnology Companies
  • 9.2 Clinical & Diagnostic Laboratories
  • 9.3 Academic & Research Institutes
  • 9.4 Contract Research Organizations
  • 9.5 Hospitals

10 Global Lab Automation Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Thermo Fisher Scientific Inc.
  • 13.2 Danaher Corporation
  • 13.3 Agilent Technologies Inc.
  • 13.4 PerkinElmer Inc.
  • 13.5 Bio-Rad Laboratories Inc.
  • 13.6 Tecan Group Ltd.
  • 13.7 Hamilton Company
  • 13.8 Eppendorf SE
  • 13.9 Qiagen N.V.
  • 13.10 Beckman Coulter Inc.
  • 13.11 Roche Diagnostics International Ltd.
  • 13.12 Siemens Healthineers AG
  • 13.13 Hudson Robotics Inc.
  • 13.14 Aurora Biomed Inc.
  • 13.15 Becton Dickinson and Company

List of Tables

  • Table 1 Global Lab Automation Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Lab Automation Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Lab Automation Market Outlook, By Equipment (2023-2034) ($MN)
  • Table 4 Global Lab Automation Market Outlook, By Automated Workstations (2023-2034) ($MN)
  • Table 5 Global Lab Automation Market Outlook, By Liquid Handling Systems (2023-2034) ($MN)
  • Table 6 Global Lab Automation Market Outlook, By Robotic Systems (2023-2034) ($MN)
  • Table 7 Global Lab Automation Market Outlook, By Microplate Readers (2023-2034) ($MN)
  • Table 8 Global Lab Automation Market Outlook, By Storage & Retrieval Systems (2023-2034) ($MN)
  • Table 9 Global Lab Automation Market Outlook, By Sample Preparation Systems (2023-2034) ($MN)
  • Table 10 Global Lab Automation Market Outlook, By Other Equipment (2023-2034) ($MN)
  • Table 11 Global Lab Automation Market Outlook, By Software & Informatics (2023-2034) ($MN)
  • Table 12 Global Lab Automation Market Outlook, By Laboratory Information Management Systems (LIMS) (2023-2034) ($MN)
  • Table 13 Global Lab Automation Market Outlook, By Electronic Lab Notebooks (ELN) (2023-2034) ($MN)
  • Table 14 Global Lab Automation Market Outlook, By Scientific Data Management Systems (SDMS) (2023-2034) ($MN)
  • Table 15 Global Lab Automation Market Outlook, By Workflow Automation Software (2023-2034) ($MN)
  • Table 16 Global Lab Automation Market Outlook, By Services (2023-2034) ($MN)
  • Table 17 Global Lab Automation Market Outlook, By Installation & Integration (2023-2034) ($MN)
  • Table 18 Global Lab Automation Market Outlook, By Maintenance & Support (2023-2034) ($MN)
  • Table 19 Global Lab Automation Market Outlook, By Consulting Services (2023-2034) ($MN)
  • Table 20 Global Lab Automation Market Outlook, By Automation Type (2023-2034) ($MN)
  • Table 21 Global Lab Automation Market Outlook, By Total Laboratory Automation (2023-2034) ($MN)
  • Table 22 Global Lab Automation Market Outlook, By Modular Automation (2023-2034) ($MN)
  • Table 23 Global Lab Automation Market Outlook, By Task-Targeted Automation (2023-2034) ($MN)
  • Table 24 Global Lab Automation Market Outlook, By Workflow Stage (2023-2034) ($MN)
  • Table 25 Global Lab Automation Market Outlook, By Pre-Analytical Automation (2023-2034) ($MN)
  • Table 26 Global Lab Automation Market Outlook, By Analytical Automation (2023-2034) ($MN)
  • Table 27 Global Lab Automation Market Outlook, By Post-Analytical Automation (2023-2034) ($MN)
  • Table 28 Global Lab Automation Market Outlook, By Application (2023-2034) ($MN)
  • Table 29 Global Lab Automation Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 30 Global Lab Automation Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 31 Global Lab Automation Market Outlook, By Genomics & Proteomics (2023-2034) ($MN)
  • Table 32 Global Lab Automation Market Outlook, By Microbiology (2023-2034) ($MN)
  • Table 33 Global Lab Automation Market Outlook, By Biobanking (2023-2034) ($MN)
  • Table 34 Global Lab Automation Market Outlook, By High-Throughput Screening (2023-2034) ($MN)
  • Table 35 Global Lab Automation Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 36 Global Lab Automation Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 Global Lab Automation Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 38 Global Lab Automation Market Outlook, By Clinical & Diagnostic Laboratories (2023-2034) ($MN)
  • Table 39 Global Lab Automation Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 40 Global Lab Automation Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 41 Global Lab Automation Market Outlook, By Hospitals (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.